Health
Diabetes treatment may protect against COVID-19 mortality – Medical News Today
A study involving a diverse patient population suggests that a diabetes drug, metformin, may help reduce the risk of COVID-19 mortality.
A critical area of COVID-19 research has focused on the risk factors that may make a person more likely to either get a SARS-CoV-2 infection or die from COVID-19 if they develop it.
SARS-CoV-2 is a novel coronavirus, and while it bears some similarities to other coronaviruses, there is still much that researchers are yet to uncover about how and why it affects some people more than others and how to mitigate the risks.
Studies have begun to emerge demonstrating associations between specific health…
-
Business24 hours agoIs Warren Buffett’s Berkshire Hathaway the smartest investment you can make today?
-
Noosa News10 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
General24 hours agoTaiwan’s President Lai Ching-te calls for peace and dialogue with China while also calling for defence boosts
-
Noosa News18 hours agoCountdown on for Noosa Eat & Drink Festival 2025